We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03608618
Recruitment Status : Terminated (Sponsor shift in focus)
First Posted : August 1, 2018
Last Update Posted : September 5, 2021
CTI Clinical Trial and Consulting Services
Information provided by (Responsible Party):
MaxCyte, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : February 11, 2021
Actual Study Completion Date : August 24, 2021